Compare
BullFrog AI Holdings, Inc. vs Silo Pharma, Inc. vs Clene Inc. vs HCW Biologics Inc.
| Latest fiscal year | BullFrog AI Holdings, Inc. BFRG | Silo Pharma, Inc. SILO | Clene Inc. CLNN | HCW Biologics Inc. HCWB |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $116.7K | $72.1K | $200.0K | $54.2K |
| Revenue growth (YoY) | n/a | 0.0% | -41.5% | -97.9% |
| Gross margin | 18.8% | 38.6% | 78.5% (computed) | 20.0% |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$6.50M | -$4.23M | -$26.17M | -$7.96M |
| EPS (Diluted) | -$0.63 | -$0.50 | n/a | -$10.63 |
| Operating cash flow | -$5.52M | -$4.66M | -$18.55M | -$13.39M |
| Free cash flow | n/a | n/a | -$18.59M | -$13.39M |
| Cash & equivalents | $2.18M | $4.75M | $5.19M | $1.95M |
| Total assets | $2.81M | $7.61M | $18.13M | $24.52M |
| Total liabilities | $672.0K | $1.30M | $35.72M | $21.76M |
| Shareholders' equity | $2.14M | $6.31M | -$17.59M | $2.76M |
| Return on year-end equity | -304.2% | -67.0% | n/a | -287.9% |
| Shares outstanding | 11.42M | 13.32M | 10.85M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | BullFrog AI Holdings, Inc. | Silo Pharma, Inc. | Clene Inc. | HCW Biologics Inc. |
|---|---|---|---|---|
| Latest | $116.7K Ended 2025-12-31 | $72.1K Ended 2025-12-31 | $200.0K Ended 2025-12-31 | $54.2K Ended 2025-12-31 |
| 1 year earlier | n/a | $72.1K Ended 2024-12-31 | $342.0K Ended 2024-12-31 | $2.57M Ended 2024-12-31 |
| 2 years earlier | $65.0K Ended 2023-12-31 | $72.1K Ended 2023-12-31 | $654.0K Ended 2023-12-31 | $2.84M Ended 2023-12-31 |
| 3 years earlier | $10.0K Ended 2022-12-31 | $72.1K Ended 2022-12-31 | $473.0K Ended 2022-12-31 | $6.72M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $723.0K Ended 2021-12-31 | $0 Ended 2021-12-31 |